Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.48%||160.69||0.7%||$1221.58m|
|MRK||Merck & Co., Inc.||0.35%||76.67||0.7%||$965.72m|
|BMY||Bristol-Myers Squibb Co.||1.00%||64.45||1.0%||$731.74m|
|LLY||Eli Lilly & Co.||1.65%||186.01||1.1%||$577.53m|
|RPRX||Royalty Pharma Plc||-1.12%||41.65||0.2%||$157.73m|
|ATNF||180 Life Sciences Corp.||-4.02%||10.04||0.0%||$60.80m|
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.